GB Sciences announced preclinical results for their Parkinson's disease (PD) formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of ...
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies…